Synthesis and biological evaluation of tricarbonyl technetium labeled 2-(4-chloro)phenyl-imidazo[1,2-a]pyridine analog (99mTcCB257) as a TSPO-binding ligand
최지영, 정재호, 송인호, 문병석, 이병철, 김상은,
소속 상세정보
최지영 ( Choi Ji-Young )
Seoul National University Graduate School of Convergence Science and Technology Department of Transdisciplinary Studies
정재호 ( Jung Jae-Ho )
Seoul National University College of Medicine Seoul National University Bundang Hospital Department of Nuclear Medicine
송인호 ( Song In-Ho )
Seoul National University College of Medicine Seoul National University Bundang Hospital Department of Nuclear Medicine
문병석 ( Moon Byung-Seok )
Seoul National University College of Medicine Seoul National University Bundang Hospital Department of Nuclear Medicine
이병철 ( Lee Byung-Chul )
Seoul National University College of Medicine Seoul National University Bundang Hospital Department of Nuclear Medicine
김상은 ( Kim Sang-Eun )
Seoul National University College of Medicine Seoul National University Bundang Hospital Department of Nuclear Medicine
Abstract
In our previous study, tricarbonyl 99mTc-labeled TSPO-binding ligand, named 99mTc-CB256, having positively charge (+1) was investigated but did not show promising results in in vivo environment despite of a nanomolar binding affinity for TSPO. Because the overall positively charge of 99mTc-CB256 would likely interrupt its target protein uptake, we herein designed the neutral tricarbonyl-99mTc labeled TSPO-binding ligand (99mTc-CB257, 1). 99mTc-CB257 was prepared by the facile incorporation of the [99mTc(CO)3]+ into a N-(hydroxycarbonylmethyl)2-picoly moiety in CB257. The radiochemical yield of 99mTc-CB257 after HPLC purification was 54.1 ± 2.4% (decay corrected, n = 3). The authentic Re-CB257 (2) was synthesized by using (NEt4)2[Re(CO)3Br3] in 69.0% yield. The binding affinity of 2 for TSPO was measured in leukocyte and showed approximately 280 times higher than that observed for the positively charged (+1) ligand, Re-CB256 ( K i = 0.57 ± 0.06 nM versus 159.3 ± 8.7 nM, respectively). Our results indicated that 1 can be considered potentially as a new SPECT radiotracer for TSPO-rich cancer and provides the foundation for further in vivo evaluation related with abnormal TSPOoverexpression environments
키워드
Translocator protein (TSPO); Tricarbonyltechnetium-99m; SPECT
원문 및 링크아웃 정보
등재저널 정보